Boston Scientific (BSX) Change in Cash (2009 - 2026)

Boston Scientific has disclosed Change in Cash across 18 years of filings, most recently posting -$504.0 million for Q1 2026.

• Change in Cash for Q1 2026 came in at -$504.0 million, down 260.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $723.0 million (up 145.85% YoY), and the FY2025 annual result was $1.5 billion, up 442.44% from the prior year.
• Change in Cash came in at -$504.0 million for Q1 2026 at Boston Scientific, down from $671.0 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $1.4 billion in Q1 2024 to a low of -$2.0 billion in Q4 2024.
• The 5-year median for Change in Cash is -$71.0 million (2022), against an average of -$30.9 million.
• Across the five-year window, Change in Cash surged 6888.89% in 2022 and sank 2554.55% in 2024, its largest moves.
• Boston Scientific's Change in Cash stood at $629.0 million in 2022, then tumbled by 112.24% to -$77.0 million in 2023, then tumbled by 2554.55% to -$2.0 billion in 2024, then soared by 132.83% to $671.0 million in 2025, then tumbled by 175.11% to -$504.0 million in 2026.
• The last three Change in Cash figures came in at -$504.0 million (Q1 2026), $671.0 million (Q4 2025), and $735.0 million (Q3 2025), per Business Quant data.